MedTrace Logo

Burden, Mortality and Supply Costs in Intensive Care Unit Patients

NCT04094428 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2024-01-17

No results posted yet for this study

Summary

This study systematically observes in a pragmatic trail under real world conditions the association between strategies of therapy (maximal therapy, withhold, withdraw) and treatment success in three endpoint related initial risk groups (high, intermediate, low risk) regarding three endpoints (burden, mortality and supply costs).

Conditions

  • Burden, Dependency
  • Mortality
  • End-of-life Care
  • Intensive Care Unit
  • Critically Ill Patient
  • Frailty
  • Multiple Organ Failure

Sponsors & Collaborators

  • University of Ulm

    lead OTHER

Principal Investigators

  • Manfred Weiss, MD, MBA · University Hospital Medical School

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-21
Primary Completion
2025-12-31
Completion
2026-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04094428 on ClinicalTrials.gov